NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 247 filers reported holding NEKTAR THERAPEUTICS in Q4 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 250 | -42.5% | 0.00% | – |
| Q2 2022 | $1,000 | -50.0% | 435 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -60.0% | 435 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -44.4% | 435 | -18.7% | 0.00% | – |
| Q3 2021 | $9,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -10.0% | 535 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | 0.0% | 535 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | -33.3% | 535 | -40.7% | 0.00% | -100.0% |
| Q3 2020 | $15,000 | -21.1% | 902 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $19,000 | +26.7% | 902 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $15,000 | -21.1% | 902 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $19,000 | +18.8% | 902 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $16,000 | -56.8% | 902 | -14.3% | 0.00% | -50.0% |
| Q2 2019 | $37,000 | -2.6% | 1,052 | -8.7% | 0.00% | -33.3% |
| Q1 2019 | $38,000 | 0.0% | 1,152 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $38,000 | -49.3% | 1,152 | -6.5% | 0.00% | -40.0% |
| Q3 2018 | $75,000 | +25.0% | 1,232 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $60,000 | -11.8% | 1,232 | +92.2% | 0.01% | -16.7% |
| Q1 2018 | $68,000 | – | 641 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |